This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
A condition of this approval is Amcor agreeing to divest its Tobepal operation comprising two plants that have combined sales of approximately EUR110 million and produce a range of pharmaceutical, personal care and food packaging products. The plants are located in Spain and are part of the Amcor Flexibles operations.
The divestment undertaking was required to meet the European Commissions' concern relating to pharmaceutical sachet and aluminium cold-form foil products.
The transaction remains subject to regulatory approval in the United States and consultation with the European Works Council.
The combined Amcor and Alcan Packaging businesses in Europe currently have sales of approximately USD4.8 billion in 75 plants.
Amcor's Managing Director and CEO, Mr Ken MacKenzie, said: "Receiving approval from the European Commission is an important step toward closing the Alcan Packaging acquisition. The two plants to be divested represent less than 5% of the combined sales in Europe and will not have a material affect on the synergies or operational improvements anticipated."
The divestment undertaking was required to meet the European Commissions' concern relating to pharmaceutical sachet and aluminium cold-form foil products.
The transaction remains subject to regulatory approval in the United States and consultation with the European Works Council.
The combined Amcor and Alcan Packaging businesses in Europe currently have sales of approximately USD4.8 billion in 75 plants.
Amcor's Managing Director and CEO, Mr Ken MacKenzie, said: "Receiving approval from the European Commission is an important step toward closing the Alcan Packaging acquisition. The two plants to be divested represent less than 5% of the combined sales in Europe and will not have a material affect on the synergies or operational improvements anticipated."
Companies in this press-release
